KIOXIA Holdings
Japanese pharmaceutical company.
Enterprise value
$14.0b
Share price
JPY2388.00
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
* | N/A | N/A Valuation: SGD7.0b | IPO |
| Total Funding | 000k | ||
Bain Capital(exited)
Bank Of Tokyo - Mitsubishi UFJ(exited)
Mizuho(exited)
Mitsubishi UFJ Financial Group(exited)
| JPY | 2025 | 2026 | 2027 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | (10 %) | 9 % |
| EBITDA | 0000 | 0000 | 0000 |
| % EBITDA margin | 45 % | 36 % | 37 % |
| Profit | 0000 | 0000 | 0000 |
| % profit margin | 16 % | 8 % | 12 % |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Investments by KIOXIA Holdings
Edit
ACQUISITION by KIOXIA Holdings Feb 2022
ACQUISITION by KIOXIA Holdings Jun 2022
